WellBeing International

WBI Studies Repository
2013

Prolonged Pain Research in Mice: Trends in Reference to the 3Rs
Jonathan Balcombe
Independent Scientist and Author

Hope Ferdowsian
George Mason University

Lauren Briese
Physicians Committee for Responsible Medicine

Follow this and additional works at: https://www.wellbeingintlstudiesrepository.org/acwp_arte
Part of the Animal Experimentation and Research Commons, Animal Studies Commons, and the
Bioethics and Medical Ethics Commons

Recommended Citation
Balcombe, J., Ferdowsian, H., & Briese, L. (2013). Prolonged pain research in mice: Trends in reference to
the 3Rs. Journal of Applied Animal Welfare Science, 16, 77-95.

This material is brought to you for free and open access
by WellBeing International. It has been accepted for
inclusion by an authorized administrator of the WBI
Studies Repository. For more information, please contact
wbisr-info@wellbeingintl.org.

Prolonged Pain Research in Mice:
Trends in Reference to the 3Rs

Jonathan Balcombe, Hope Ferdowsian, and Lauren Briese

Recommended Citation:
Balcombe, J., Ferdowsian, H., & Briese, L. (2013). Prolonged pain research in mice:
Trends in reference to the 3Rs. Journal of Applied Animal Welfare Science, 16, 7795.

Keywords: mice, pain, 3Rs, trends

ABSTRACT
This literature review documents trends in the use of mice in prolonged pain
research, defined herein as research that subjects mice to a source of pain for at
least 14 days. The total amount of prolonged pain research on mice has increased
dramatically in the past decade for the 3 pain categories examined: neuropathic,
inflammatory, and chronic pain. There has also been a significant rise in the
number of prolonged mouse pain studies as a proportion of all mouse studies and
of all mouse pain studies. The use of transgenic mice has also risen significantly in
prolonged pain research, though not as a proportion of all mice used in prolonged
pain research. There has not been significant overall change in the number of mice
being used per study for any of the 3 pain categories or for any of 3 common pain
inducement models: chronic constriction injury, partial sciatic nerve ligation, and
complete Freund’s adjuvant. Finally, although most authors referred to approval of
experiments by an institutional nonhuman animal use committee, there were no
references to the “3Rs” in a random selection of 55 papers examined. Given the
proportionally high volume of mice used in invasive research and the gravity of
studies that inflict lasting pain, these trends raise serious questions about whether
the 3Rs principles of Replacement, Reduction, and Refinement are being
appropriately implemented by researchers and institutions.

INTRODUCTION
The year 2009 marked the 50th anniversary since publication of the landmark text
The Principles of Humane Experimental Technique by William Russell and Rex Burch
(1959). Russell and Burch’s book spawned “the 3Rs,” a widely accepted ethical
framework for the use of nonhuman animals in research, testing, and education.
The 3Rs framework seeks Replacement of animals with nonanimal methods,
Reduction in the number of animals used, and Refinement to minimize animal pain
and suffering. The avoidance of pain and its treatment with analgesics are
paramount priorities in animal research (National Research Council [NRC], 2007).
By some measures, the 3Rs have yielded progress, especially in the arena of animal
testing. For example, there has been a movement toward in vitro and
computational methods in toxicology testing following a 2007 landmark report by
the U.S. National Research Council (NRC, 2007). This report represents a significant
paradigm shift; there have also been important changes to specific testing
protocols. Figures are not readily available, but The Lethal Dose 50% (LD50) test
has been altered so that it causes suffering to fewer animals; the “up-and-down”
method reduces by more than 70% the number of animals required (Lichtman,
1998) and is estimated to have spared at least 10,000 mice from the LD50 test
over the past decade (M. Stephens, Johns Hopkins University Center for
Alternatives to Animal Testing, personal communication, April 15, 2011). In the
area of research, replacement of the painful ascites method with nonanimal
methods for the production of monoclonal antibodies (McArdle, Reddington,
Reddington, & Heidel, 1996) has spared more than 2 million mice yearly worldwide.
Strides have also been made in the areas of vaccine potency and biologics testing,
among others.
However, other reported trends suggest notable failures in 3Rs implementation
(Taylor, Gordon, Langley, & Higgins, 2008). The use of animals in pain experiments
is an area of special welfare concern because animals are deliberately subjected to
pain-inducing procedures, and pain relief is typically withheld as part of the study
design. The number of animals used in pain experiments has increased significantly
over the past several decades. Between 1963 and 2007, the number of published
papers describing pain experiments in animals increased by more than 20-fold
(Mogil, 2009). Although the number of studies using dogs, cats, rabbits, and other
animals in pain experiments has remained relatively stable with some fluctuations,
there has been a dramatic increase in the number of published studies of rats and
mice in pain experiments (Mogil, 2009).
Mice (Mus musculus) in the laboratory comprise a large proportion of the estimated
100 million vertebrate animals currently used worldwide for animal experimentation
each year (Taylor et al., 2008). By our own estimates, the number of mouse pain

studies averaged fewer than 5 per year between 1963 and 1976, increased to at
least 30 studies per year by 1991, and has expanded to over 200 studies per year
since 2006. In 2010, the number of pain studies using mice decreased slightly for
the first time since 2003.
The aim of this study was to quantify trends in the use of laboratory mice, including
transgenic mice, in a subset of pain research that is of particular concern for animal
welfare: studies in which animals are subjected to prolonged pain. We addressed
six questions:
1. Has the total amount of research using mice in prolonged pain research
changed through time?
2. Has the proportion of studies using mice in prolonged pain research
changed relative to the total number of mice used in research or mice used
in pain research?
3. Has the use of transgenic mice in prolonged pain research changed
through time?
4. Has the number of mice per study being used in prolonged pain research
changed through time?
5. Has the number of mice per study for a given pain model changed through
time?
6. To what degree are researchers reporting efforts to implement 3Rs in their
studies?
Questions 1 through 5 address the possibility of efforts at Reduction and/or
Replacement of mice in prolonged pain research. Question 6 addresses possible
efforts to implement all three Rs, including Refinement, in the use of mice in this
research. Any declines in absolute or proportional numbers of mice being used can
be seen as success in the areas of Reduction and Replacement. To date, a detailed
analysis of such trends is lacking, and this analysis can provide a useful assessment
of progress in implementing the 3Rs.
MATERIALS AND METHODS
Literature Searches
We conducted literature searches using PubMed, a free online version of MEDLINE
that also includes up-to-date citations not yet indexed for MEDLINE. Date of
publication was determined by date of printed journal in which the article appeared
(i.e., not e-publication date for which electronic versions of papers may appear in
the prior calendar year). We conducted searches using the string “mouse AND pain

AND [pain category].” The three pain categories we used were “neuropathic,”
“inflammatory,” and “chronic.”
Inclusion and Exclusion Criteria
Studies were selected for analysis based on the following two inclusion criteria: (a)
studies involving mice (transgenic and/or wild-type) and (b) studies that sought to
subject mice to prolonged pain (we used this term only to define the duration of
pain and to avoid confusion with one of our pain categories, “chronic pain”).
Prolonged pain studies were those in which mice were subjected to the source of
pain for 14 or more days. Although there is no standard definition of what qualifies
as prolonged pain in mice, we consulted three independent experts in the field of
rodent pain research before conservatively selecting the 14-day criterion.
Studies were included in the analysis if any of the mice met the 14-day criterion.
We excluded from our analysis studies not in English, studies of acute pain or stress
(e.g., acute thermal or mechanical nociception), in vitro studies, and drug
(including alcohol and tobacco) withdrawal studies. The most common reason for
excluding a study from the analysis was that the source of pain lasted less than 14
days. Other types of studies omitted from our literature search included review
papers, studies of rats, and in vitro studies.
Pain Research Categories
For the remainder of the analysis, we focused on three categories of pain research:
neuropathic, inflammatory, and chronic pain. We used the search terms “mouse
AND [category of] pain” in conjunction with each of these three categories,
respectively. We found some overlap across these pain categories, such as when
researchers induced both neuropathic and inflammatory pain in mice. In cases
where a given study qualified for more than one pain category, we assigned it to
the predominant one (based on numbers of mice used) to avoid counting a study
more than once.
Methods of Pain Inducement
We used the methods sections of published papers to identify the primary method
by which prolonged pain was induced in all qualifying studies.
Total Amount of Prolonged Mouse Pain Research (Question 1)
To address the total volume of prolonged pain studies being done on mice, we
simply plotted the number of qualifying (prolonged mouse pain) studies by year.
Proportion of Studies Subjecting Mice to Prolonged Pain (Question 2)
An overall increase in the number of studies in which mice are being subjected to
prolonged pain could reflect an increase in the number of researchers doing mouse

pain research. To address this possibility we examined the number of mice being
used in prolonged pain studies as a proportion of all mouse studies and as a
proportion of all mouse pain studies. We performed literature searches using the
PubMed database and the search term “mouse” and compared the number of hits
with the number of qualifying studies we identified for each year across all three
pain categories. We also compared qualifying studies with a Boolean search for
“mouse AND pain.” Because there were so few qualifying studies prior to 2000, we
limited this analysis to the years 2000 to 2010.
Use of Transgenic Mice (Question 3)
We identified prolonged mouse pain studies in which one or more mouse strains
used were transgenic. We assessed the yearly frequency of the number of these
studies in comparison to the number of prolonged mouse pain studies using only
nontransgenic mouse strains. We also recorded the number of prolonged pain
studies using transgenic mice as a proportion of all prolonged mouse pain studies
for a given year to see if any trends in relative use of transgenic mice emerged.
In a few studies, transgenic mice were reported to have suppressed pain
responses; in others, pain responses were amplified. In our analysis we did not
distinguish these factors on the grounds that suppressed pain response cannot be
assumed to be an indication of less pain and vice versa.
Number of Mice Used per Study (Question 4)
To evaluate possible trends in the number of mice used per study, we randomly
selected three qualifying studies per pain category (neuropathic, inflammatory, and
chronic) for a given publication year and attempted to ascertain the number of mice
used in those studies. In years for which fewer than three qualifying studies were
published, we included all studies published that year in the analysis. Each paper
was carefully reviewed to determine, as best as possible, the number of mice used.
Methods sections, figures, and tables were the most likely places to find information
on sample sizes. Authors often provided a range in numbers of mice used in various
experiments; in these cases we estimated the minimum and maximum number of
mice used and used the mean of these two estimates. Within a qualifying study,
only those mice subjected to painful stimuli for 14 days or more were included in
this analysis. Control groups were included if they were subjected to the pain
inducement method (e.g., controls were a different strain of mouse) and excluded if
they were not (e.g., sham-operated animals). Two authors (J. B., L. B.)
independently conducted counts of a subsample of papers to establish concordance
of the counting method.

Use of Mice in Specific Pain Models (Question 5)
We evaluated the possibility that researchers may be using fewer mice in prolonged
pain studies for specific pain models. For each year we compared the average
number of mice used in a random selection of up to five qualifying studies with the
average number of mice used in up to five nonqualifying studies that used the same
model. Nonqualifying studies were those flagged in original literature searches that
did not to meet our inclusion criteria. We selected the three most commonly used
pain models for this analysis: chronic constriction injury (CCI), partial sciatic nerve
ligation (PSNL), and complete Freund’s adjuvant (CFA). Sample sizes for some
years were small, and because few applicable studies occurred before 2000, we
used the average of all pre-2000 studies for a given category. In years for which
there were three or more studies in a particular category, we randomly selected
three studies.
We also compared the overall means of all individual mouse counts (all years
combined) between qualifying and nonqualifying studies within each of the three
pain models.
Reporting 3Rs Efforts (Question 6)
To evaluate the degree to which researchers are reporting efforts to implement 3Rs
in their studies, we performed searches for the following keywords in selected
papers: “3Rs,” “Reduc[e][tion],” “Replace,” “Refine,” “Humane,” “Minimize,”
“Guide[line],” and “Ethic.” We also performed searches for language pertaining to
committee approval. We randomly selected five papers per year for this analysis
and pooled data for qualifying studies published before 2000 (n = 9).
We recorded whether each given term appeared at least once in the published
paper. We took care to include terms only when they were used in the context of
relieving animal pain and/or suffering. Certain terms (especially “reduce”) often
occurred out of this context.
Other Trends
We compiled a list of the different methods used to induce prolonged pain in mice.
We also noted the countries in which the research was carried out.
Statistics
Nonnormal distributions of data, and in some cases small sample sizes, favored the
use of nonparametric statistics in this study. To evaluate whether or not the
proportion of studies using mice in prolonged pain research has changed through
time (Question 2), we used the Jonckheere-Terpstra test for trend (Jonckheere,
1954), a nonparametric test for the null hypothesis that the distribution of a data

set does not differ across time (in our study, years). We also used the Jonckheere
test to assess the possibility of yearly trends in the use of transgenic mice
(Question 3).
We used the Spearman’s rho correlation test to assess the possibility of yearly
trends in the number of mice being used per study for each pain category (Question
4) and for numbers of mice being used per study within our three selected pain
inducement models (Question 5). We used the Wilcoxon test to compare overall
means for the three pain inducement methods.
To evaluate the reporting of efforts to implement 3Rs in studies of prolonged mouse
pain (Question 6), we used the Jonckheere-Terpstra test for trend, which
accommodates small sample sizes.
Because so few qualifying studies were published before 2000, and because we
were applying nonparametric statistics to the data, studies published before 2000
were pooled for the trends analysis of the number of mice per study (Question 5).
RESULTS
Methods of Inducing Pain
A wide variety of methods are used to induce prolonged pain in mice and other
animal subjects of pain research (Table 1). We identified 26 different methods used
in the studies we examined. The most commonly used of these methods fell under
the neuropathic pain category and involved variations on the theme of eliminating
or compromising a given nerve by transection, ligation, or partial ligation. In
particular, CCI and PSNL have remained popular since their initial development in
1988 (Bennett & Xie, 1988) and 1990 (Seltzer, Dubner, & Shir, 1990), respectively.
We found that the administration of CFA is another commonly used method of
inducing prolonged inflammatory pain in mice (Chillingworth & Donaldson, 2003).
Total Amount of Prolonged Mouse Pain Research (Question 1)
We identified a total of 320 studies published between 1979 and 2010 that met our
inclusion criteria for prolonged pain. The volume of studies focused on neuropathic
models of pain (n D 201) was substantially higher than models of chronic pain (n D
70) or inflammatory pain (n D 49; Figure 1). The three most recent years of our
analysis (2008–2010) yielded more studies (202, 63%) than all previous years
combined (118, 37%). Most of this recent increase is attributable to neuropathic
pain studies; the volume of prolonged pain research using mice in inflammatory
and chronic pain models has remained fairly stable since 2006.

Table 1. Common methods used to induce prolonged pain in mice and rats

Method
Chronic constriction injury
Partial sciatic nerve ligation
Complete Freund’s adjuvant
Sciatic nerve ligation or injury
Spared nerve injury
Spinal nerve ligation or injury
Other nerve injuries (saphenous, infraorbital, etc.)
Injections of painful compounds
Diabetes (usually via streptozotocin)
Bone cancer (tumor cell implantation)
Peripheral nerve injury
Arthritis
Colitis
Colorectal distension
Endometriosis
Schistosomiasis
Surgical pain
Viral infection (e.g., herpes)
Dental pain (drilling)
Induced fibromyalgia
Tail vertebra compression
Fish venom
Chronic pancreatitis
Amyotrophic lateral sclerosis
Temporal–mandibular joint
Human sickle hemoglobin
Total

Predominant Pain
Category
Neuropathic
Neuropathic
Chronic
Neuropathic
Neuropathic
Neuropathic
Chronic
Inflammatory
Neuropathic
Chronic
Neuropathic
Inflammatory
Inflammatory
Inflammatory
Inflammatory
Chronic
Chronic
Chronic
Inflammatory
Neuropathic
Inflammatory
Inflammatory
Chronic
Inflammatory
Inflammatory
Neuropathic

Number of
Studies
50
39
30
29
28
24
21
19
17
15
11
8
4
4
3
2
2
2
1
1
1
1
1
1
1
1
316

Proportion of Studies Subjecting Mice to Prolonged Pain (Question 2)
We found strong evidence of a trend in the number of prolonged mouse pain
studies as a proportion of all mouse studies (p < .0001 using Jonckheere-Terpstra
test) and as a proportion of all mouse pain studies (p < .0001) for years 2000 to
2010 (Figure 2).
Use of Transgenic Mice (Question 3)
The overall use of transgenic mice in prolonged pain research has increased over
time (p < .0001 using Jonckheere-Terpstra for years 2000–2010; Figure 3).
However, when taken as a proportion of all prolonged mouse pain studies, we did
not find a significant trend in the use of transgenic mice in this body of research
(Jonckheere-Terpstra p D .45 for years 2000–2010; Figure 4).

Figure 1. Number of prolonged pain studies using mice in three categories of pain research
(neuropathic pain, inflammatory pain, and chronic pain) based on PubMed MeSH search conducted on
April 26, 2011.

Number of Mice Used per Study (Question 4)
Ascertaining the number of animals used in a study and the number of mice
subjected to painful stimuli versus control animals was difficult for many of the
articles we reviewed. In about 20% of all papers examined, sample sizes were
clearly stated. However, in most cases, mouse counts required careful examination
of the paper. Results sections, and especially figure captions, were the most likely
places to find sample sizes, but even then the data were often too vague to
ascertain exact numbers.
Typically, between 40 and 80 mice were subjected to prolonged pain in a given
study (Figure 5), but the range was from fewer than 10 to several hundred mice.
We did not find statistically significant trends across years in the number of mice
being subjected to prolonged pain in any of the three pain categories. Spearman’s
rho p values were .70 for neuropathic pain studies, .07 for inflammatory pain
studies, and .10 for chronic pain studies.

Figure 2. Number of prolonged mouse pain studies as a proportion of (a) all mouse studies and (b) all
mouse pain studies.

Use of Mice in Specific Pain Models (Question 5)
We did not find significant trends in the number of mice used per study for the
three most commonly used pain models we examined (Figure 6). JonckheereTerpstra trend analyses produced the following results: CCI qualifying studies,
p=.18, n=30, nonqualifying studies, p=.21, n=12; PSNL qualifying studies, p=.69,
n=23, nonqualifying studies, p=.29, n=26; and CFA qualifying studies, p=.35,
n=13, nonqualifying studies, p=.48, n=9.

Figure 3. Number of prolonged mouse pain studies using transgenic mice published since 2000.

Figure 4. Number of prolongedmouse pain studies using transgenic mice as a proportion of all
prolonged pain studies.

Figure 5. Number of mice per study subjected to prolonged pain by pain category. n=3 for each bar
from 2004 onward; n ≤ 3 for each bar preceding 2004.

Figure 6. Mean numbers of mice per study for qualifying (prolonged pain) and nonqualifying studies
by pain model. Each bar represents the yearly mean number of mice used per study. (a) CCI =
chronic constriction injury model; (b) PSNL = partial sciatic nerve ligation (note different vertical
scale); (c) CFA = complete Freund’s adjuvant. q = qualifying studies; n = nonqualifying studies.

The distributions of the number of mice between qualifying and nonqualifying
studies did not differ for any of the three pain models. Wilcoxon tests yielded
p = .41 for CCI studies, p = .31 for PSNL studies, and p = .22 for CFA studies
(Figure 7).
Reporting 3Rs Efforts (Question 6)
None of the 55 studies used in this analysis reported any of the following keywords
directly associated with the 3Rs framework: 3Rs, Reduce, Replace, or Refine. The
terms humane, minimize, and ethic were mentioned in 2 (4%), 4 (7%), and 9
(16%) studies, respectively. Many authors (24 studies, 44%) referred either to a
guideline or guide, and a majority (39, 71%) referred to approval of the protocols
by an institutional animal use committee (Figure 8).
Figure 9. Comparison of mean (+SD) numbers of mice used per study for qualifying (prolonged pain)
and nonqualifying studies by pain model. Each bar represents the mean of all studies in each
category. CCI = chronic constriction injury model; PSNL = partial sciatic nerve ligation; CFA =
complete Freund’s adjuvant; Q = qualifying studies; NQ = nonqualifying studies. Sample sizes are in
parentheses.

There was not a trend through time for any of the aforementioned terms, with the
exception of guideline, which showed an increasing proportion of studies through
time (Jonckheere-Terpstra trend test p = .0017).

Figure 8. Proportion of yearly sample of published studies in which specific keywords were mentioned
in the context of the 3Rs (Reduce, Refine, or Replace). Each bar represents a proportion of five studies
with the exception of 2000 (three studies) and 2002 (two studies). No studies mentioned the 3Rs, so
they are not shown here.

Geographic Patterns of Use
The studies qualifying for inclusion in our general analysis were conducted in a total
of 27 different countries (Table 2). The United States led the list with 106 studies.
Japan (62 studies), Germany (39), the United Kingdom (34), Canada (20), and
Italy (14) rounded out the remaining top 5 countries. Europe was represented by
14 countries (including Turkey); Asia by 6 (including the Ukraine); and there were
2 each from North America and the Middle East (Israel and Iran) and 1 each from
Africa (Cameroon), Latin America (Brazil), and Australia.
DISCUSSION
Research that inflicts pain, particularly research that causes prolonged unrelieved
pain, is of special concern from an ethical perspective. Our analysis documents both
an absolute and a proportional rise in the total volume of prolonged mouse pain
studies during the past 15 years and in particular a dramatic rise in research that
subjects mice to prolonged neuropathic pain during the last 3 years of the analysis
(2008–2010). These trends illustrate a failure in one of the 3Rs: Replacement.
Notwithstanding these overall increases, the most recent years’ data suggest a
possible plateau in the volume of total mouse prolonged-pain research. It has been
suggested that pain researchers may be reverting to the use of rats, which were
the favored subjects of animal pain research before mice came to the fore (Colleoni
& Sacerdote, 2009; Mogil 2009). If so, this would not be a success from the 3Rs
perspective.

Table 2. Number of Qualifying Studies by Country

Country
United States
Japan
Germany
United Kingdom
Canada
Italy
Spain
France
Brazil
South Korea
Sweden
Belgium
China
Poland
Switzerland
Israel
Denmark
Hungary
India
Taiwan
Australia
Austria
Iran
Cameroon
Netherlands
Turkey
Ukraine
Total

Neuropathic
Pain
54
50
30
28
8
14
9
10
5
5
5
4
6
4
6
2
3
1
1
1
1
1
0
1
1
1
0
251

Inflammatory
Pain
19
7
2
2
5
1
2
1
5
3
1
1
0
1
0
0
0
1
0
1
0
0
0
0
0
0
1
53

Chronic
Pain
33
5
7
4
7
3
3
2
1
2
1
1
0
1
0
2
0
1
2
1
1
1
2
0
0
0
0
80

Total
106
62
39
34
20
18
14
13
11
10
7
6
6
6
6
4
3
3
3
3
2
2
2
1
1
1
1
384

Note: Some studies were represented by more than one country.

It is interesting to note that although the use of transgenic mouse strains in
prolonged mouse pain research has risen steadily over the past decade, the
proportion of studies using transgenic mice has not grown. Thus, the proportional
rise in prolonged mouse pain research is not solely attributable to an influx of
transgenic models. Nevertheless, there has been a proliferation of transgenic
mouse strains, and as of 2009 there were 274 different knockout mice reported to
have pain phenotypes (Colleoni & Sacerdote, 2009; Mogil, 2009).We caution
against interpreting the use of transgenic mice as constituting a Refinement; some
transgenic strains have shown behavioral evidence for enhanced (e.g., Helyes et

al., 2009; Racz et al., 2008), and some reduced (e.g., Chessell et al., 2005;
Hughes, Hatcher, & Chessell, 2007), sensitivity to pain.
A drop in the number of mice used per study might mitigate the rising numbers and
proportion of studies using mice and would represent a measure of success in
meeting one of the 3Rs: Reduction. We found no such trend across any of the three
pain categories we examined (neuropathic, inflammatory, and chronic). Thus, there
does not appear to be any direct effort on the part of prolonged mouse pain
researchers to implement reductions in the numbers of animals they are using.
By evaluating the number of mice used per study for three specific models of pain,
we addressed the possibility that reduction efforts may be occurring in particular
branches of pain research. Once again, we did not find evidence that the number of
mice per study was declining through time for any of the three pain models
examined. We also did not find any significant difference in the number of mice
being used in studies that qualified as prolonged pain compared with studies
subjecting mice to shorter periods of pain for any of the three specific pain models
(e.g., chronic constriction injury). It is possible that pain researchers in other fields
(e.g., cancer pain) are making measurable efforts to subject fewer mice to
prolonged pain, but we did not find evidence of this for the pain categories we
examined.
That the 3Rs or any of the 3Rs components—Replace, Reduce, or Refine—were not
mentioned in any of 55 studies suggests that prolonged mouse pain researchers
may be unaware of or indifferent to the 3Rs framework and that this aspect is not
considered relevant in the peer review process of manuscripts for scientific journals.
A small percentage of authors did mention efforts to minimize the number of
animals and/or pain caused to animals in their studies. Our findings reflect a recent
analysis of 250 research papers reporting experiments on primates and mice which
found that reporting using the 3Rs is very low and not increasing (Taylor, 2011).
Most often, authors referred to efforts to abide by a set of guidelines, such as those
of the International Association for the Study of Pain (IASP, 2012), or approval by
the researchers’ institutional animal use committees.
Our finding that only the term “guideline” showed a significant increase in usage
through time might suggest that adherence to guidelines by themselves is adequate
to ensure 3Rs progress. However, the growing proportion of the number of studies
subjecting mice to prolonged pain and the lack of any change in the number of mice
being subjected to prolonged pain reported elsewhere in this paper suggests that
adherence to guidelines and/or animal use committee requirements is not
translating into significant progress from a reduction or replacement perspective.
The geographic distribution of prolonged pain research using mice reflects global
patterns of overall animal use in research, so we did not find a disproportionate

distribution of prolonged mouse pain research per se. The United States is the
world’s largest user of animals in research, and the same is true for studies of
prolonged pain in mice. The next five highest users—Japan, Germany, the United
Kingdom, Canada, and Italy—all rank among the world’s primary overall users of
animals in experimentation.
There are limitations of our study. The dearth of qualifying studies published before
2004, and especially before 2000, hindered our ability to determine early trends in
the number of mice being used per study because often the number of studies for a
given pain category year was one or zero. The difficulty of estimating how many
mice were used in a given study was another limitation. In some studies it is
virtually impossible to determine the exact numbers of mice used, as noted by
other authors (Hampson, Southee, Howell, & Balls, 1990).
CONCLUSION
Studies that induce prolonged pain are a high priority for the application of the 3Rs
principles. However, our findings suggest that researchers conducting prolonged
pain research on mice are paying little, if any, heed to 3Rs principles in the
planning and execution of their research. The trends we present here constitute a
measurable failure in two of the 3Rs established by Russell and Burch in their 1959
book: a failure to Replace animal-based methods with nonanimal methods and a
failure to Reduce the number of animals being used.
Alternative approaches exist for replacing and reducing animal use and for refining
methods to minimize pain and suffering, and this is a very active area of research
(Goldberg, 2007). In the area of pain research, ethical clinical studies with human
patients have the advantage that humans can reliably report their experience of
pain and pain relief (Brown, Seymour, Boyle, El-Deredy, & Jones, 2008).When it is
coupled with brain imaging technologies, self-reporting of pain offers a powerful
approach to the understanding and treatment of pain (Jones & Watson, 2007).
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